1. Musa R, Brent LH, Qurie A. Lupus Nephritis. StatPearls. 2021. https://www.ncbi.nlm.nih.gov/books/NBK499817/
2. Anders HJ, Saxena R, Zhao M hui, Parodis I, Salmon JE, Mohan C. Lupus nephritis. Nature Reviews Disease Primers. 2020;6(1). doi:10.1038/s41572-019-0141-9
3. Liu Y, Anders HJ. Lupus nephritis: From pathogenesis to targets for biologic treatment. Nephron - Clinical Practice. 2014;128:224-231. doi:10.1159/000368581
4. Brent LH. Lupus Nephritis. Medscape. Published February 25, 2021. https://emedicine.medscape.com/article/330369-overview#a7
5. Mejia-Vilet JM, Rovin BH. Epidemiology and management of lupus nephritis. In: Dubois’ Lupus Erythematosus and Related Syndromes. Elsevier; 2018:727-744.
6. Barber MRW, Drenkard C, Falasinnu T, et al. Global epidemiology of systemic lupus erythematosus. Nature Reviews Rheumatology. 2021;17(9):515-532. doi:10.1038/s41584-021-00668-1
7. Gandhi K, Alemao E, Kawabata H, Hillson JL, Squibb BM. Prevalence Of Systemic Lupus Erythematosus and Lupus Nephritis In The United States: Analysis Of Commercial and Public Insurance Billing Data. ACR/AHRP Annual Meeting. 2013.
8. Yap DYH, Chan TM. Lupus Nephritis in Asia: Clinical Features and Management. Kidney Diseases. 2015;1(2):100-109. doi:10.1159/000430458
9. Kementrian Kesehatan Indonesia. Situasi Lupus di Indonesia. Pusdatin. Published online 2017.
10. Yap DYH, Tang CSO, Ma MKM, Lam MF, Chan TM. Survival analysis and causes of mortality in patients with lupus nephritis. Nephrology Dialysis Transplantation. 2012;27(8):3248-3254. doi:10.1093/ndt/gfs073
11. Stanton M, Tiwari V. Polyarteritis Nodosa. StatPearls. 2021.
12. Priyatha Garlapati, Ahmad Qurie. Granulomatosis with Polyangiitis. StatPearls. 2021.
13. Perhimpunan Rematologi Indonesia. Diagnosis Dan Pengelolaan Lupus Eritematosus Sistemik. 2019.
14. Bhat P, Radhakrishnan J. B lymphocytes and lupus nephritis: New insights into pathogenesis and targeted therapies. Kidney International. 2008;73(3):261-268.
15. Ntatsaki E, Isenberg D. Risk factors for renal disease in systemic lupus erythematosus and their clinical implications. Expert Review of Clinical Immunology. 2015;11(7):837-848
16. Bao L, Cunningham PN, Quigg RJ. Complement in Lupus Nephritis: New Perspectives. Kidney Dis 2015;1:91-99.
17. Enocsson H, Gullstrand B, Eloranta ML, Wettero J, Leonard D, Ronnblom L, et al. C-Reactive Protein Levels in Systemic Lupus Erythematosus Are Modulated by the Interferon Gene Signature and CRP Gene Polymorphism rs1205. Front Immunol, 2021;11:622326.
18. Kammoun K, Jarraya F, Bouhamed L, Kharrat M, Makni S, Hmida MB, et al. Poor prognostic factors of lupus nephritis. Saudi J Kidney Dis Transpl. 2011; 22(4):727-32.
19. Almaani S, Meara A, dan Rovin BH. Update on Lupus Nephritis. Glomerular Diseases: Update for the Clinician. CJASN May 2017, 12 (5) 825-835; DOI: https://doi.org/10.2215/CJN.05780616
20. Hoover, Paul J, and Karen H Costenbader. “Insights into the epidemiology and management of lupus nephritis from the US rheumatologist's perspective.” Kidney international vol. 90,3 (2016): 487-92. doi:10.1016/j.kint.2016.03.042
21. Kasjmir YI, Handono K, Wijaya LK, Hamijoyo L, Albar Z, et al. Rekomendasi Perhimpunan Reumatologi Indonesia untuk Diagnosis dan Pengelolaan Lupus Eritematosus Sistemik. 2011. ISBN 978-979-3730-16-5. https://reumatologi.or.id/wp-content/uploads/2020/10/Rekomendasi_Lupus_Eritematosus_Sistemik_2011.pdf
22. Pesickova SS, Rysava R, Lenicek M, et al. Prognostic value of anti-CRP antibodies in lupus nephritis in long-term follow-up. Arthritis Res Ther. 2015;17:371. Published 2015 Dec 24. doi:10.1186/s13075-015-0879-8
23. Enocsson H, Karlsson J, Li H.-Y, Wu Y, Kushner I, et al. The Complex Role of C-Reactive Protein in Systemic Lupus Erythematosus. J. Clin. Med. 2021, 10, 5837. https://doi.org/10.3390/jcm10245837
24. Yip TC, Saria S, Petri M, Magder LS. Predictors of the start of declining eGFR in patients with systemic lupus erythematosus. Lupus. 2021;30(1):15-24. doi:10.1177/0961203320966393
25. YH Aini, A Tjandrawati, N Suraya, L Hamijoyo. Correlation of Random Urine Protein Creatinine (P-C) Ratio with 24-Hour Protein Urine in Lupus Nephritis Patients. Indonesian Journal of Rheumatology 2016; Vol 8
26. Khairallah, M.K., Makarem, Y.S. & Dahpy, M.A. Vitamin D in active systemic lupus erythematosus and lupus nephritis: a forgotten player. Egypt J Intern Med 32, 16 (2020). https://doi.org/10.1186/s43162-020-00016-x
27. Rifa A, Kalim H, Kusworini, Wahono CS. Effect of vitamin D supplementation on disease activity (SLEDAI) and fatigue in Systemic Lupus Erythematosus patients with hipovitamin D: An Open Clinical Trial. Indonesian Journal of Rheumatology 2016; Vol 8 No.2
28. Falk RJ, Dall’Era M, Appel GB. Lupus nephritis: Initial and subsequent therapy for focal or diffuse lupus nephritis. Uptodate. 2022.
29. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M. The classification of glomerulonephritis in systemic lupus erythematosus revisited. International Society of Nephrology Working Group on the Classification of Lupus Nephritis, Renal Pathology Society Working Group on the Classification of Lupus Nephritis. Kidney Int. 2004;65(2):521.
30. Bajema IM, Wilhelmus S, Alpers CE, Bruijn JA, Colvin RB, Cook HT, D'Agati VD, Ferrario F, Haas M, Jennette JC, Joh K, Nast CC, Noël LH, Rijnink EC, Roberts ISD, Seshan SV, Sethi S, Fogo AB. Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int. 2018;93(4):789. Epub 2018 Feb 16.
31. Lu J, Tam LS, Lai FM, Kwan BC, Choi PC, Li EK, Chow KM, Li PK, Szeto CC. Repeat renal biopsy in lupus nephritis: a change in histological pattern is common. Am J Nephrol. 2011;34(3):220.
32. Contreras G, Pardo V, Cely C, Borja E, Hurtado A, De La Cuesta C, Iqbal K, Lenz O, Asif A, Nahar N, Leclerq B, Leon C, Schulman I, Ramirez-Seijas F, Paredes A, Cepero A, Khan T, Pachon F, Tozman E, Barreto G, Hoffman D, Almeida Suarez M, Busse JC, Esquenazi M, Esquenazi A, Garcia Mayol L, Garcia Estrada H. Factors associated with poor outcomes in patients with lupus nephritis. Lupus. 2005;14(11):890.
33. Costedoat-Chalumeau N, Houssiau FA. Improving medication adherence in patients with lupus nephritis. Kidney Int. 2021;99(2):285.
34. Falk RJ, Dall’Era M, Appel GB. Lupus nephritis: Treatment of focal or diffuse lupus nephritis resistant to initial therapy. Uptodate. 2022.
35. Gladman DD, Tandon A, Ibañez D, Urowitz MB. The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications. J Rheumatol. 2010 Apr;37(4):754-8. Epub 2010 Mar 15.
36. Saavedra MA, Cruz-Reyes C, Vera-Lastra O, Romero GT, Cruz-Cruz P, Arias-Flores R, Jara LJ. Impact of previous lupus nephritis on maternal and fetal outcomes during pregnancy. Clin Rheumatol. 2012 May;31(5):813-9. Epub 2012 Jan 27.